Skip to content

Clinical Study on the Effects of Hard Einstein Nervonic Acid-based Adult Formula Milk Powder on Improving Adult Cognitive Function

Clinical Study on the Effects of Hard Einstein Nervonic Acid-based Adult Formula Milk Powder on Improving Adult Cognitive Function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119044
Enrollment
Unknown
Registered
2026-02-14
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

intervention group:Add one sachet (25 g) of milk powder to 150 ml of warm water (50?), stir thoroughly until dissolved, and consume twice daily, once in the morning and once in the evening.

Sponsors

Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18–65 years, no gender restrictions; 2. Subjective complaints of memory impairment or cognitive decline, with a Montreal Cognitive Assessment (MoCA) score >= 26; 3. Good physical health with no history of neurological, psychiatric, or major systemic diseases; normal physical examination, complete blood count, and liver/kidney function prior to enrollment; vital signs (temperature, blood pressure) within normal ranges; no metabolic disorders; 4. Able to comprehend the study objectives and voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Suffering from severe chronic diseases such as cardiovascular or respiratory conditions; 2. Suffering from organic brain damage or dementia; 3. Currently taking or having taken within the past 3 months any medication or health supplement designed to enhance cognitive function; 4. Allergies to milk protein or other product ingredients; 5. Communication or language barriers preventing independent completion of questionnaires or completion with staff assistance; 6. Planning to become pregnant or currently pregnant; 7. Participants deemed medically unsuitable for this study by the investigator.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment Scale ;Digital Breadth Test;Symbol-to-Number Conversion Test;

Secondary

MeasureTime frame
SOD;GSH-Px;TNF-a;IL-6;

Countries

China

Contacts

Public ContactXie Weining

Guangdong Hospital of Integrated Traditional Chinese and Western Medicine

xwn1219@qq.com+86 134 3168 6846

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026